Table 2.

Prevalence of orofacial symptoms and dysfunction in the JIA group (n = 265) and the control group (n = 200).

VariablesJIA GroupControl GroupMeasures (95% CI)p
Orofacial symptoms
  No symptoms178 (67.2)148 (74.0)
  ≥ 1 symptom87 (32.8)52 (26.0)OR 1.4 (0.91–2.14)0.11
  TMJ pain65 (24.5)14 (7.0)OR 4.32 (2.30–8.60)< 0.001*
  TMJ morning stiffness42 (15.8)9 (4.5)OR 4.02 (1.86–9.60)< 0.001*
  Orofacial muscle pain74 (27.9)44 (22.0)OR 1.07 (0.70–1.66)0.74
  Limitation on chewing35 (13.2)9 (4.5)OR 3.24 (1.48–7.85)0.001*
  Locking of the jaw20 (7.5)17 (8.5)OR 0.88 (0.42–1.84)0.71
Orofacial pain intensity
  VAS pain > 0, median (IQR)25 (5–85)19 (6–60)Z = 0.630.53
Orofacial pain frequency
  Pain frequency > 0, median (IQR)1 (1–4)11 (1–3)1Z = 2.61< 0.01*
Orofacial pain profile
  Pain index > 02, median (IQR)30 (5–260)20 (6–120)Z = 1.530.13
No. symptoms
  Per subject, median (IQR)2 (1–5)1 (1–3)Z = 2.260.02*
Orofacial dysfunctions
  No dysfunctions129 (48.7)112 (56.0)
  ≥ 1 dysfunction136 (51.3)88 (44.0)OR 1.34 (0.91–1.97)0.12
  Reduced MIO351 (19.2)3 (1.5)OR 15.72 (4.94–79.69)< 0.001*
  TMJ pain on palpation79 (29.9)42 (21.0)OR 0.62 (0.40–0.95)0.03*
  Orofacial pain on palpation67 (25.3)50 (25.0)OR 0.99 (0.64–1.50)0.94
  Asymmetric mouth opening29 (10.9)32 (16.0)OR 0.65 (0.36–1.15)0.11
No. dysfunctions
  Per subject, median (IQR)1 (0–2)0 (0–2)Z = 2.340.02*
  • Values indicate n (%) unless otherwise indicated.

  • * Statistical significance (p ≤ 0.05).

  • 1 Pain frequency: 1 indicates not every week; 2 = several times a week; 3 = several times a day; 4 = all the time.

  • 2 Pain index: pain frequency × pain intensity.

  • 3 MIO < −2 SD below mean of normative values (< 40.9 mm, ref 27). JIA: juvenile idiopathic arthritis; TMJ: temporomandibular joint; VAS: visual analog scale; IQR: interquartile range; MIO: maximal incisal opening.